2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

Exercise Change trial: a randomized trial of the National Cancer Institute of
Canada Clinical Trials Group. Curr Oncol. 2008;15:271-278.
48. Meyerhardt JA, Ma J, Courneya KS. Energetics in colorectal and
prostate cancer. J Clin Oncol. 2010;28:4066-4073.
49. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Impact of body mass
index and weight change after treatment on cancer recurrence and survival in
patients with stage III colon cancer: findings from Cancer and Leukemia
Group B 89803. J Clin Oncol. 2008;26:4109-4115.
50. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary
patterns with cancer recurrence and survival in patients with stage III colon
cancer. JAMA. 2007;298:754-764.
51. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to
prevent colorectal adenomas. N Engl J Med. 2003;348:891-899.
52. Baron JA, Sandler RS, Bresalier RS, et al. A randomized trial of
rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology.
2006;131:1674-1682.
53. Bertagnolli MM, Eagle CJ, Zauber AG, et al. Celecoxib for the prevention
of sporadic colorectal adenomas. N Engl J Med. 2006;355:873-884.
54. Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long-term use of
aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal
cancer. JAMA. 2005;294:914-923.
230
ANDRÉ, O’NEIL, AND MEYERHARDT
55. Fuchs C, Meyerhardt JA, Heseltine DL, et al. Influence of regular
aspirin use on survival for patients with stage III colon cancer: findings from
Intergroup trial CALGB 89803. J Clin Oncol. 2005;23: (suppl abstr 3530).
56. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis
of colorectal cancer. JAMA. 2009;302:649-659.
57. Kerr DJ, Dunn JA, Langman MJ, et al. VICTOR: a phase III placebocontrolled
trial of rofecoxib in colorectal cancer patients following surgical
resection. J Clin Oncol. 2008;26: (suppl abstr 4038).
58. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status
for colorectal cancer prevention: a quantitative meta analysis. Am J Prev
Med. 2007;32:210-216.
59. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d
levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26:
2984-2991.
60. Ng K, Wolpin BM, Meyerhardt JA, et al. Prospective study of predictors
of vitamin D status and survival in patients with colorectal cancer. Br J
Cancer. 2009;101:916-923.
61. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil,
and leucovorin as adjuvant treatment for colon cancer. N Engl J Med.
2004;350:2343-2351.